Rituximab in Pretreated Elderly or Unfit B-CLL Patients
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Rituximab
Related studies linked through entity extraction aliases.
A Pilot Study to Assess the Efficacy of Rituximab Therapy in Treatment Resistant FSGS
- Status
- COMPLETED
- Phase
- PHASE2
Comparison of Rituximab Induction Therapy Followed by Glatiramer Acetate
- Status
- COMPLETED
- Phase
- PHASE2
Study Evaluating the Efficacy and Safety of Idelalisib in Combination With Bendamustine and Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL) (Tugela )
- Status
- COMPLETED
- Phase
- PHASE3
Combination of Oral Fludarabine, Mitoxantrone Und Rituximab Induction Therapy and Rituximab Maintenance Therapy in Follicular B-Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Low Dose Rituximab in Thrombotic Thrombocytopenic Purpura
- Status
- COMPLETED
- Phase
- PHASE2
Phase 2 Study of Zevalin Versus Zevalin and Motexafin Gadolinium in Patients With Rituximab-Refractory Low-grade or Follicular B-cell Non-Hodgkin's Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
Lenalidomide Plus Rituximab for Recurrent/Refractory CNS and Intraocular Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
A Randomized, Double-Blind, Placebo-Controlled Study of Idelalisib in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
- Status
- COMPLETED
- Phase
- PHASE3
Rituximab and Combination Chemotherapy in Treating Patients With Previously Untreated High- or High-Intermediate-Risk Diffuse Large B-Cell Lymphoma
- Status
- WITHDRAWN
- Phase
- PHASE2
Provide Initial Evidence of Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy to Support the Pivotal CT-P10 Therapeutic Equivalence Trial
- Status
- TERMINATED
- Phase
- PHASE1
Demonstrate the Equivalence of CT-P10 to MabThera With Respect to the Pharmacokinetic Profile in Patients With Rheumatoid Arthritis
- Status
- COMPLETED
- Phase
- PHASE1
rhTPO Combining Rituximab Versus Low-dose Rituximab in Management of ITP
- Status
- COMPLETED
- Phase
- PHASE3
Tolerance and Efficacy of Subcutanous Low Doses Rituximab for CLL Consolidation Treatment
- Status
- UNKNOWN
- Phase
- PHASE2
Phase 2 Study of the Combination of Bruton's Tyrosine Kinase Inhibitor PCI-32765 and Rituximab in High-Risk Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma Patients
- Status
- COMPLETED
- Phase
- PHASE2
Study of Zevalin Versus Observation in Participants at Least 60 Years Old With Newly Diagnosed Diffuse Large B-cell Lymphoma in Positron Emission Tomography (PET)-Negative Complete Remission After Rituximab-Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) or R-CHOP-like Therapy
- Status
- TERMINATED
- Phase
- PHASE3
HLA-haploidentical Hematopoietic Stem Cell Transplantation for Children and Adolescents With Acute Leukemia, Myelodysplastic Syndrome and Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Phase II Study of Fractionated 90Y Ibritumomab Tiuxetan (Zevalin) Radioimmunotherapy as an Initial Therapy of Follicular Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Zevalin-Containing Nonmyeloablative Conditioning for Stem Cell Transplantation (SCT)
- Status
- COMPLETED
- Phase
- PHASE2
Rituxan/Bendamustine/PCI-32765 in Relapsed DLBCL, MCL, or Indolent Non-Hodgkin's Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1